Allarity Therapeutics, Inc. financial statements
Allarity Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 320K | 10-K |
| Net income | −USD 11.23M | 10-K |
| Cash and equivalents | USD 14.69M | 10-Q |
| Total debt | USD 1.4M | EODHD |
Allarity Therapeutics, Inc. financials on 6ix · Allarity Therapeutics, Inc. on 6ix